RD
Ravi Dineshkumar Bhavsar
About Ravi Dineshkumar Bhavsar
Data last updated:
Ravi Dineshkumar Bhavsar is a Director at Solisky Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals and Materials. Solisky Pharmaceuticals Private Limited reported revenue of ₹73.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Sep 2021 | 2021 | ₹73.3 Lakh (FY 2025) | Active |
Board colleagues of Ravi Dineshkumar Bhavsar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Darshan Navinchandra Jani | 09317226 | Solisky Pharmaceuticals Private Limited | Director |
| Krunal Ashokbhai Thakor | 09317227 | Solisky Pharmaceuticals Private Limited | Director |
| Yash Bhavsar | 09317228 | Solisky Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Dineshkumar Bhavsar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Dineshkumar Bhavsar
Ravi Dineshkumar Bhavsar currently holds 1 directorship: Solisky Pharmaceuticals Private Limited (Director, since 13 Sep 2021, revenue ₹73.3 Lakh (FY 2025)).
Ravi Dineshkumar Bhavsar was first appointed on 13 Sep 2021 as Director at Solisky Pharmaceuticals Private Limited.
The current boards of Ravi Dineshkumar Bhavsar's companies include Darshan Navinchandra Jani (Solisky Pharmaceuticals Private Limited), Krunal Ashokbhai Thakor (Solisky Pharmaceuticals Private Limited), Yash Bhavsar (Solisky Pharmaceuticals Private Limited).